Perhaps the NHS shouldn't - not paying for Humira would essentially obliterate AbbVie's UK market, which would make a considerable dent in their profits... I guess that would probably make them re-think their pricing structure!

However, presumably the treatment is "worth" the NHS paying for it - even if it is massively overpriced. I can't really pass comment on their medication choices.